CrossRef Evodiamine targets ZO-1 to ameliorate cholestatic liver disease: Intestinal homeostasis as the core mediator of gut-liver axis repair and bile acid metabolism remodeling Shuxin Yan, Yao Zhang, Qiqi Fan, Wenwen Jia, Yihang Dai, Xinlin Li, Shan Lu, Yuhan Sheng, Shuang Sun, Ruichao Lin, Yang Tang, Chongjun Zhao Phytomedicine .2026
For the full #fastfive episode, sponsored by the Alvarez & Marsal Consumer and Retail Group, Mirakl, Ocampo Capital, Quorso, & Veloq, head here: To view or add a comment, sign in Forward-looking perspective from Bridget O'Connell, Director of Payor Relations and Business Development and Tess Carey, Lead Clinical Pharmacist at Amazon Pharmacy, as they share how the collaboration with Experity continues to evolve

CrossRef Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events Daqiu Chen, Zixun Wang, Zhanxiong Xie, Yixing Chen, Shunxiang Luo, Shanghua Xu Frontiers in Pharmacology.2026;[Epub] CrossRef Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study Ying Wang, Hongning Li, Zhongyuan Zhang, Xiaocen Kong, Huiqin Li, Weichun Qian, Jianhua Ma Frontiers in Endocrinology.2026;[Epub] CrossRef Inflammation-autonomic cross talk contributes to left ventricular diastolic dysfunction in type 2 diabetes: a rationale for neuromodulation Nuwani Wijesooriya, Senali Silva, Dulani Kottahachchi, Nadisha Badanasinghe, Dinu S
Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy